3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Conditions
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Urologic Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Breast Neoplasms
1
Basal Cell Carcinoma of the Head and Neck
1
Interventions
pembrolizumab
17
Nivolumab
6
Docetaxel
6
Gemcitabine
5
Cisplatin
5
Carboplatin
5
durvalumab
4
Paclitaxel
4
Ipilimumab
4
avelumab
3
atezolizumab
3
Filgrastim
3
Cyclophosphamide
3
Bortezomib
3
130-nm albumin-bound paclitaxel
3
tremelimumab
2
tislelizumab
2
spartalizumab
2
fludarabine
2
epacadostat
2
enzalutamide
2
aldesleukin
2
abiraterone
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Nicotine
2
Irinotecan
2
Interleukin-2
2
Injections
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Tissue Banks
×
Head & Neck
×
Clear all
NCT07550049
2026-04-24
COMETH
University of Kansas Medical Center
Not yet recruiting
110 enrolled